101
Participants
Start Date
April 30, 2016
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Naltrexone
daily dosing
Placebo
daily dosing
Buprenorphine
daily dosing
New York State Psychiatric Institute, New York
Western Psychiatric Institute and Clinic of University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania Treatment Research Center, Philadelphia
Duke University Medical Center, Durham
Segal Institute for Clinical Research, Lauderhill
Research Centers of America, LLC, Oakland Park
Neuroscience Research Institute, Inc., Winfield
John Hopkins School of Medicine, Baltimore
Hassman Research Institute, Berlin
Lead Sponsor
Alkermes, Inc.
INDUSTRY